Numab Therapeutics, an oncology-focused biopharmaceutical company based near Zurich, has closed an oversubscribed Sfr100m (US$111m) Series C financing. Proceeds will support acceleration and expansion of the clinical development of Numab’s…
Numab Therapeutics, an oncology-focused biopharmaceutical company based near Zurich, has closed an oversubscribed Sfr100m (US$111m) Series C financing. Proceeds will support acceleration and expansion of the clinical development of Numab’s…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference